Reuters - The U.S. Medicare agency will ask an advisory panel for input on the use of Amgen and Johnson & Johnson anemia drugs in patients with chronic kidney disease, officials said on Thursday.
Reuters - The U.S. Medicare agency will ask an advisory panel for input on the use of Amgen and Johnson & Johnson anemia drugs in patients with chronic kidney disease, officials said on Thursday.
